Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Rhea-AI Summary
Whitehawk Therapeutics (Nasdaq: WHWK) announced that Dave Lennon, PhD, President and CEO, will participate in a fireside discussion at the Piper Sandler 37th Annual Healthcare Conference in New York City on December 3, 2025 at 12:30 PM ET. A live webcast will be available on the company's investor relations website and will be replayable for approximately 30 days after the event.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, WHWK gained 6.98%, reflecting a notable positive market reaction. This price movement added approximately $7M to the company's valuation, bringing the market cap to $108M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers in Biotechnology showed mixed moves: IFRX -5.56%, PTHS -5.49%, SRZN -1.57%, while IPA +3.50% and ORMP +4.66%. With no momentum scanner flags and conflicting peer directions, WHWK trading appears more stock-specific than sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 01 | Executive hire | Positive | -3.4% | Appointment of experienced oncology CMO to support ADC development. |
| Nov 26 | Conference appearance | Neutral | +7.0% | Announcement of CEO fireside chat at Piper Sandler healthcare conference. |
| Nov 11 | Conference appearance | Neutral | +2.3% | Upcoming CEO presentation at Jefferies Global Healthcare Conference in London. |
| Nov 06 | Earnings update | Negative | -6.7% | Q3 2025 results with larger net loss despite stronger cash position. |
| Oct 24 | Scientific data | Positive | -1.6% | Real-world PTK7 expression analysis supporting HWK-007 ADC targeting strategy. |
Recent conference and scientific updates often coincided with modest to negative moves, while the Jefferies and Piper Sandler appearance headlines previously saw small gains. Positive R&D or hiring news has not consistently translated into sustained price strength.
Over the last few months, Whitehawk reported a strategic pivot to a preclinical ADC portfolio, highlighted in Q3 2025 earnings on Nov 6 with higher cash balances but wider losses. Scientific data on PTK7 presented on Oct 24 underscored its target strategy, yet drew a slightly negative reaction. Conference participation at Jefferies on Nov 18 and Piper Sandler on Dec 3, plus the CMO appointment on Dec 1, show a focus on visibility and team building, with share moves alternating between modest gains and pullbacks.
Market Pulse Summary
The stock moved +7.0% in the session following this news. A strong positive reaction aligns with past instances where conference participation headlines, such as Jefferies and Piper Sandler events, were followed by gains of up to 6.98%. However, other positive scientific and hiring updates previously saw negative moves, suggesting sentiment can reverse quickly. Investors watching a surge may have weighed the broader context of a preclinical ADC story and past volatility around earnings and data updates.
Key Terms
antibody drug conjugate medical
AI-generated analysis. Not financial advice.
A live webcast of the fireside chat can be accessed by visiting the Whitehawk Therapeutics IR website and will be available for replay for approximately 30 days following the event.
About Whitehawk Therapeutics
Whitehawk Therapeutics is an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Whitehawk's advanced three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed from
Contact:
IR@whitehawktx.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference-302626225.html
SOURCE Whitehawk Therapeutics, Inc.
FAQ
When will Whitehawk Therapeutics (WHWK) present at the Piper Sandler 2025 conference?
How can investors watch the Whitehawk Therapeutics (WHWK) fireside chat on December 3, 2025?
Will the Whitehawk Therapeutics (WHWK) webcast be available after the Piper Sandler conference?
Who will represent Whitehawk Therapeutics (WHWK) at the Piper Sandler 37th Annual Healthcare Conference?
Where is the Piper Sandler 37th Annual Healthcare Conference taking place for the Whitehawk Therapeutics (WHWK) presentation?
